CN101906060A - N-取代的3-氨甲基吡咯烷的制备方法 - Google Patents
N-取代的3-氨甲基吡咯烷的制备方法 Download PDFInfo
- Publication number
- CN101906060A CN101906060A CN201010163408.2A CN201010163408A CN101906060A CN 101906060 A CN101906060 A CN 101906060A CN 201010163408 A CN201010163408 A CN 201010163408A CN 101906060 A CN101906060 A CN 101906060A
- Authority
- CN
- China
- Prior art keywords
- compound
- preparation
- aminomethyl pyrrolidine
- replaces
- pyrrolidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- -1 N-substituted 3-aminomethyl pyrrolidine Chemical class 0.000 title claims abstract description 14
- 238000006243 chemical reaction Methods 0.000 claims abstract description 26
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 claims abstract description 10
- 230000004224 protection Effects 0.000 claims abstract description 5
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 150000001875 compounds Chemical class 0.000 claims description 27
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical group C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 20
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
- OQCUGPQOZNYIMV-UHFFFAOYSA-N pyrrolidin-3-ylmethanamine Chemical compound NCC1CCNC1 OQCUGPQOZNYIMV-UHFFFAOYSA-N 0.000 claims description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 10
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 10
- MEKOFIRRDATTAG-UHFFFAOYSA-N 2,2,5,8-tetramethyl-3,4-dihydrochromen-6-ol Chemical compound C1CC(C)(C)OC2=C1C(C)=C(O)C=C2C MEKOFIRRDATTAG-UHFFFAOYSA-N 0.000 claims description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- ZWWQRMFIZFPUAA-UHFFFAOYSA-N dimethyl 2-methylidenebutanedioate Chemical compound COC(=O)CC(=C)C(=O)OC ZWWQRMFIZFPUAA-UHFFFAOYSA-N 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 230000007062 hydrolysis Effects 0.000 claims description 2
- 238000006460 hydrolysis reaction Methods 0.000 claims description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims 4
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical group O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 claims 2
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims 1
- 238000005903 acid hydrolysis reaction Methods 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims 1
- 229910052763 palladium Inorganic materials 0.000 claims 1
- 230000006103 sulfonylation Effects 0.000 claims 1
- 238000005694 sulfonylation reaction Methods 0.000 claims 1
- AWRPXOMRXIZAIW-UHFFFAOYSA-N tert-butyl 1-(aminomethyl)pyrrolidine-3-carboxylate Chemical compound CC(C)(C)OC(=O)C1CCN(CN)C1 AWRPXOMRXIZAIW-UHFFFAOYSA-N 0.000 abstract description 11
- SUAKIVNGQVUKJA-UHFFFAOYSA-N (1-benzylpyrrolidin-3-yl)methanamine Chemical compound C1C(CN)CCN1CC1=CC=CC=C1 SUAKIVNGQVUKJA-UHFFFAOYSA-N 0.000 abstract description 10
- 238000005984 hydrogenation reaction Methods 0.000 abstract description 4
- 238000000034 method Methods 0.000 abstract description 2
- 238000007363 ring formation reaction Methods 0.000 abstract description 2
- LVHBHZANLOWSRM-UHFFFAOYSA-N itaconic acid Chemical compound OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 abstract 1
- 238000006722 reduction reaction Methods 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- 239000000047 product Substances 0.000 description 11
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 239000012044 organic layer Substances 0.000 description 8
- 238000012544 monitoring process Methods 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 5
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 239000000543 intermediate Substances 0.000 description 5
- IOAGBFOCXFRONA-UHFFFAOYSA-N tert-butyl 2-(aminomethyl)-1-benzylpyrrolidine-3-carboxylate Chemical compound NCC1C(C(=O)OC(C)(C)C)CCN1CC1=CC=CC=C1 IOAGBFOCXFRONA-UHFFFAOYSA-N 0.000 description 5
- 150000004702 methyl esters Chemical class 0.000 description 4
- 229940079593 drug Drugs 0.000 description 3
- 238000003810 ethyl acetate extraction Methods 0.000 description 3
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- OJRDXHVHSXHQOG-UHFFFAOYSA-N C1(=CC=CC=C1)CN1CCCC1=C=O.CC1=C(C(=O)O)C=CC=C1C(=O)O Chemical compound C1(=CC=CC=C1)CN1CCCC1=C=O.CC1=C(C(=O)O)C=CC=C1C(=O)O OJRDXHVHSXHQOG-UHFFFAOYSA-N 0.000 description 2
- 241000725303 Human immunodeficiency virus Species 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000009514 concussion Effects 0.000 description 2
- 239000012280 lithium aluminium hydride Substances 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 2
- 235000011121 sodium hydroxide Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- MFPWEWYKQYMWRO-UHFFFAOYSA-N tert-butyl carboxy carbonate Chemical compound CC(C)(C)OC(=O)OC(O)=O MFPWEWYKQYMWRO-UHFFFAOYSA-N 0.000 description 2
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 1
- 229940124623 antihistamine drug Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- IEISBKIVLDXSMZ-UHFFFAOYSA-N methdilazine hydrochloride Chemical compound Cl.C1N(C)CCC1CN1C2=CC=CC=C2SC2=CC=CC=C21 IEISBKIVLDXSMZ-UHFFFAOYSA-N 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000012450 pharmaceutical intermediate Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 150000007660 quinolones Chemical class 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Pyrrole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101634082A CN101906060B (zh) | 2010-05-06 | 2010-05-06 | N-取代的3-氨甲基吡咯烷的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101634082A CN101906060B (zh) | 2010-05-06 | 2010-05-06 | N-取代的3-氨甲基吡咯烷的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101906060A true CN101906060A (zh) | 2010-12-08 |
CN101906060B CN101906060B (zh) | 2012-07-04 |
Family
ID=43261672
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010101634082A Expired - Fee Related CN101906060B (zh) | 2010-05-06 | 2010-05-06 | N-取代的3-氨甲基吡咯烷的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101906060B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1331677A (zh) * | 1998-11-20 | 2002-01-16 | 霍夫曼-拉罗奇有限公司 | 吡咯烷衍生物-ccr-3受体拮抗剂 |
WO2003068221A1 (en) * | 2002-02-14 | 2003-08-21 | Bristol-Myers Squibb Company | Indole, azaindole and related heterocyclic pyrrolidine derivatives |
US7196200B2 (en) * | 2004-01-21 | 2007-03-27 | Abbott Laboratories | Antibacterial compounds |
-
2010
- 2010-05-06 CN CN2010101634082A patent/CN101906060B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1331677A (zh) * | 1998-11-20 | 2002-01-16 | 霍夫曼-拉罗奇有限公司 | 吡咯烷衍生物-ccr-3受体拮抗剂 |
WO2003068221A1 (en) * | 2002-02-14 | 2003-08-21 | Bristol-Myers Squibb Company | Indole, azaindole and related heterocyclic pyrrolidine derivatives |
US7196200B2 (en) * | 2004-01-21 | 2007-03-27 | Abbott Laboratories | Antibacterial compounds |
Also Published As
Publication number | Publication date |
---|---|
CN101906060B (zh) | 2012-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10934257B2 (en) | Method for preparing pimavanserin and tartrate thereof by using triphosgene | |
CN103420893B (zh) | 制备西洛多辛中间体的方法 | |
CN102633686A (zh) | 一种帕拉米韦的制备方法 | |
CN102584677B (zh) | 一种格列齐特的制备方法 | |
CN101798270A (zh) | 一种3-氨基-1-金刚烷醇的制备方法 | |
CN101239937B (zh) | 一种光学活性r-(-)-1-苄氧羰基-3-氨基吡咯烷及其盐酸盐的制备方法 | |
CN103204801A (zh) | N-Boc-3-哌啶酮的合成方法 | |
CN101137621A (zh) | 吡咯烷衍生物中间体及其制备方法和用途 | |
CN101486687B (zh) | 一种盐酸司他斯汀的制备工艺 | |
CN103012300A (zh) | 一种制备缬沙坦的新方法 | |
CN102532128A (zh) | 托烷司琼的合成方法以及盐酸托烷司琼的制备方法 | |
CN105481867A (zh) | 三步接力催化构建手性螺环氧化吲哚及其合成方法和应用 | |
CN101906060B (zh) | N-取代的3-氨甲基吡咯烷的制备方法 | |
CN104974057B (zh) | 一种溴芬酸钠的制备方法和重要中间体 | |
CN101348475B (zh) | 一种奥利司他合成方法、中间体化合物及其制备方法 | |
CN102775450A (zh) | 一种1,6-脱水-2-叠氮-2-脱氧-β-D-吡喃葡萄糖的制备方法 | |
CN102807516A (zh) | 氨磺必利的中间体及利用该中间体制备氨磺必利的方法 | |
CN102627595A (zh) | 一种制备格隆溴铵的方法 | |
CN106117104B (zh) | 一种维格列汀的制备方法 | |
JP2010116372A (ja) | 1,3−ジアルキル−2−イミダゾリジノン類の製造方法 | |
CN101973897B (zh) | 一种合成阿戈美拉汀中间体2-(7-甲氧基萘-1-基)乙胺的方法 | |
CN104045646B (zh) | 三尖杉酯碱d环中间体合成方法 | |
CN104211663B (zh) | 一种(s)-n-甲氧基-甲基-2-(四氢吡咯基)丙酰胺及其制备方法和应用 | |
CN106146507A (zh) | 一种托法替尼的合成新方法 | |
CN101412678B (zh) | 一种合成盐酸美金刚的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20101208 Assignee: Jiangsu Long Healthcare Co.,Ltd. Assignor: ACESYS PHARMATECH Ltd.|Nanjing Tech University Contract record no.: 2013320000334 Denomination of invention: Preparation method of N-substituted 3-aminomethyl pyrrolidine Granted publication date: 20120704 License type: Exclusive License Record date: 20130416 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180419 Address after: 212400 -1, 18 Xianlin East Road, Baohua Town, Jurong City, Zhenjiang, Jiangsu. Co-patentee after: Nanjing Tech University Patentee after: Jiangsu Guohua Biotechnology Co.,Ltd. Address before: 210009 Gulou District, Jiangsu, Nanjing new model road, No. 5 Co-patentee before: Nanjing Tech University Patentee before: ACESYS PHARMATECH Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120704 Termination date: 20180506 |
|
CF01 | Termination of patent right due to non-payment of annual fee |